• AMG 487 for Reliable CXCR3 Assays

  2026-09-11

  Learn how AMG 487 (SKU B3266) can clarify CXCR3-dependent migration, calcium signaling, macrophage polarization, and assay-related viability concerns. This scenario-based guide translates potency, solubility, storage, metabolism, and literature evidence into practical laboratory decisions.

• Predicting Netarsudil–siRNA Nanoparticle Codelivery

  2026-09-10

  Slaughter and colleagues developed a quantitative workflow that predicts whether ionizable drugs can complex siRNA and support nanoparticle encapsulation. Netarsudil was identified as a high-performing candidate and tested with CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, linking formulation design with changes in gene expression and actin organization.

• Tin Mesoporphyrin IX: HO Assay Workflows

  2026-09-10

  Tin Mesoporphyrin IX (chloride) provides a direct, nanomolar-affinity tool for testing whether heme oxygenase activity drives metabolic, inflammatory, or antiviral phenotypes. This article translates its biochemical profile into reproducible enzyme, cell-based, and HBV-focused workflows while separating established evidence from practical assay recommendations.

• Chuanxiong Cortex and Pith in CHD: Metabolomic Insights

  2026-09-09

  Li and colleagues compared the volatile chemistry and predicted pharmacology of Ligusticum chuanxiong cortex and pith using SPME-GC×GC-MS, network pharmacology, pathway analysis, and molecular docking. The study shows that anatomically distinct rhizome regions contain different candidate bioactive profiles, providing a more resolved framework for interpreting Chuanxiong in coronary heart disease research.

• Open-Platform DLP for 96-Well Hydrogel Printing

  2026-09-09

  The reference study introduces an open-platform digital light printer that produces spatially defined two-dimensional hydrogels and activates surface-bound biomolecules in a 96-well format. Its programmable LabVIEW control, planar correction, wavelength flexibility, and vessel compatibility address reproducibility and customization challenges in high-throughput biomaterials workflows.

• Intraperitoneal CAR-Macrophage Programming via mRNA-LNP

  2026-09-09

  Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform to compare 36 CAR designs directly in the peritoneal environment. Their lead CD3ζ–TLR4 intracellular-domain configuration promoted inflammatory macrophage activity, remodeled the tumor microenvironment, increased TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and enhanced responses to PD-1/L1 therapy.

• Machine Learning Prediction of mRNA Vaccine LNPs

  2026-09-08

  Wang and colleagues developed a LightGBM model to predict lipid nanoparticle formulations for mRNA vaccines from 325 formulation–IgG titer records. The study combined machine learning, mouse validation of DLin-MC3-DMA versus SM-102, and molecular dynamics to connect formulation variables with vaccine performance and provide a basis for virtual LNP screening.

• Reserpine (N1867): Practical Lab Workflow Guide

  2026-09-07

  Reserpine (N1867) is a high-purity research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. This guide covers identity verification, DMSO preparation, storage, and quality-control practices; it is not intended for diagnostic, therapeutic, clinical, or veterinary use.

• Berberine Hydrochloride: Assay Logic for Gut–Bone Research

  2026-09-07

  Berberine hydrochloride connects AMPK, epithelial biology, microbiota, and osteoimmune readouts. This article provides a salt-aware, causality-focused framework for integrating metabolic and gut–bone assays without overstating preclinical evidence.

• Sequencing Therapies in Waldenström Macroglobulinemia

  2026-09-04

  The 2021 reference article presents a genotype-informed framework for sequencing Waldenström macroglobulinemia therapy, emphasizing MYD88 and CXCR4 status alongside clinical presentation, comorbidities, and patient preferences. Its main practical contribution is to connect molecular subgroups with the relative roles of ibrutinib, chemoimmunotherapy, proteasome inhibitors, transplantation, and emerging clinical-trial agents.

• Foretinib, ICD, and Anti-CD47 Therapy in CRC

  2026-09-04

  A 2026 Neoplasia study identifies foretinib as an inducer of immunogenic cell death in colorectal cancer, connecting c-Met/VEGFR2 inhibition with p53–DR5 signaling, DAMP release, and immune activation. Its combination with anti-CD47 therapy provides a preclinical strategy that couples tumor-cell killing with improved immune recognition.

• Machine Learning LNPs Reprogram Microglia

  2026-09-03

  Rafiei, Shojaei, and Chau combined supervised machine learning with lipid nanoparticle screening to identify an mRNA formulation that suppresses inflammatory phenotypes in activated microglia. The study shows that carrier composition, hyaluronic acid modification, cellular state, transfection, and morphology should be evaluated together when designing immunomodulatory RNA delivery systems.

• AM 281: A Causal Assay Guide to CB1 Signaling

  2026-09-03

  AM 281 enables selective interrogation of CB1 cannabinoid receptor signaling in neuropharmacology research. This article develops an assay-centered framework for connecting receptor perturbation with astrocytic GLT-1, neuronal injury, and cognitive readouts after traumatic brain injury.

• Lithium, Exosomal Wnt10a, and BMSC Osteogenesis

  2026-09-02

  The 2024 ACS Applied Materials & Interfaces study identifies a mechanistic route by which lithium enhances bone mesenchymal stem cell osteogenesis: MARK2-associated Rab11a/Rab11FIP1 trafficking increases exosomal Wnt10a delivery and activates β-catenin signaling. Its comparison of lithium-conditioned exosomes and GelMA hydrogel formulations provides a framework for engineering exosome-based interventions for bone repair, while also highlighting important translational limitations.

• DOPE: From Membrane Fusion to Fungal Ferroptosis

  2026-09-02

  1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is best known as a fusogenic helper phospholipid for nucleic acid delivery. New evidence in Magnaporthe oryzae suggests that phosphatidylethanolamine biology can also illuminate fungal ferroptotic cell death, creating a disciplined bridge between formulation science and pathogen biology.

8518 records 6/568 page Previous Next First page 上5页 678910 下5页 Last page